Post-earnings recap
Reported
Tue, Nov 4, 2025
EPS actual
$0.18
EPS est.
$0.05
EPS surprise
+239.62%
1-day move
+1.47%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Amicus Therapeutics reported a strong earnings surprise with an EPS of $0.18, significantly exceeding expectations. The stock reacted positively, rising 1.47%. However, the lack of revenue data and forward guidance leaves some uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.18 | N/A | +239.62% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting their commitment to pipeline development. They remain focused on long-term growth.
We are pleased with our EPS performance this quarter.
Our focus remains on advancing our pipeline and delivering value.